期刊文献+

调脂保肝汤联合西药治疗非酒精性单纯脂肪肝50例 被引量:2

Treating 50 Cases of Nonacohol Haplo-Fatty Liver with Tiaozhi Baogan Decoction with Western Medicine
下载PDF
导出
摘要 目的:观察调脂保肝汤治疗非酒精性单纯脂肪肝的临床疗效。方法:将100例符合诊断标准的患者按随机数字表法分为两组,治疗组60例,对照组40例。对照组应用西药治疗,治疗组在对照组基础上加用自拟调脂保肝汤,1个疗程后比较结果。结果:治疗组临床痊愈、显效、有效、无效分别为24例、26例、6例、4例,有效率93.3%;对照组分别为8例、14例、6例、12例,有效率70.0%。两组差异有显著性(P<0.05)。结论:调脂保肝汤治疗非酒精性单纯脂肪肝疗效确实,无明显毒副作用,值得临床推广。 Objective:To observe the clinical curative effect of Nonacohol Haplo-Fatty Liver with Tiaozhi Baogan Decoction.Methods:100 cases who consistent with diagnostic code were divided into two group according to random digits table,60 csase in treatment group,40 cases in control group,the control was treated in Western Medicine,The treatment was treated with Tiaozhi Baogan Decoction on the basis of the control,compared result after 1 course of treatment.Results:The recovery is 24 cases,the excellenc is 26 cases,the effective is 6 cases,the inefficiency is 4 cases in treatment group,the total effective rate is 93.33%,8 cases,14 cases,6 cases,12 cases in control group,and the total effective is 70.0%,there were significance about the total effective of two groups by χ^2 analysis in post-treatment(P〈0.05).Conclusion:It is definite that the curative effect of Tiaozhi Baogan Decoction on Nonacohol Haplo-Fatty Liver,having no obviouse toxic and side-effect,it is worth to spread in clin.
作者 杜磊
出处 《中医学报》 CAS 2010年第2期279-280,共2页 Acta Chinese Medicine
关键词 调脂保肝汤 非酒精性单纯脂肪肝 消脂通络 Tiaozhi Baogan Decoction Nonacohol Haplo-Fatty Liver Slake lipoid dredging collaterals
  • 相关文献

参考文献4

二级参考文献14

  • 1翁维良.降血脂中草药研究进展[J].天津中医,1986,(1):34-36.
  • 2何嘉延.泽泻与高脂血症、动脉硬化和脂肪肝[J].中国中西医结合杂志,1981,(2):19-19.
  • 31,Ludwig J,Viggiano TR,McGill DB,et al.Nonalcoholic steatohepatitis:mayo clinical experiences with a hitherto unnamed disease.Mayo Clin Proc,1980;55(7):434
  • 42,Bacon BR,Farachvash MJ,Janney CG,et al.Nonalcoholic steatohepatitis:an expanded clinical entity.Gastroenterology,1994;107(4):1103
  • 53,Ludwig J,McGill DB,Lindor K.Nonalcoholic steatohepatitis.J Gastroenterol Hepatol,1997;12(5):398
  • 64,Wanless IR,Lentz JS.Fatty liver hepatitis(steatohepatitis) and obesity:an autopsy study with analysis of risk factors.Hepatology,1990;12(5):110
  • 75,Cotrim HP,Parana R,Portugal M,et al.Nonalcoholic steatohepatitis(NASH) and industrial toxins:follow up of patients removed from one industrial area(abstract).Hepatology,1997;26(suppl):149A
  • 86,Geroge DK,Goldwrum S,Macdonald GA,et al.Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increases of fibrosis.Gastroenterology,1998;114(2):311
  • 97,James LFW,Day CP.Nonalcoholic steatohepatitis(NASH):a disease of merging identity and importance.J Hepatol,1998;29(3):495
  • 108,Sorbi D,Boynton J,Linder KD.The ratio of aspartate aminotransferase to alanine aminotransferase:potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.Am J Gastroenterol,1999;94(4):1018

共引文献94

同被引文献11

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部